Viscoderm 2.0

Viscoderm 2.0 is a sterile injectable medical device by IBSA, indicated for bringing the dermis back to its normal physiological condition in cases of severe xerodermia associated with dermatitis and/or psoriasis. It is intended for intradermal administration by qualified healthcare professionals. The product contains 20 mg/ml of highly purified sodium hyaluronate obtained through fermentation.

• Sterile, single-use injectable medical device, CE 0477
• Highly purified sodium hyaluronate obtained by fermentation, not subjected to chemical modification processes
• Molecular weight of about 1 million Dalton, very close to endogenous hyaluronic acid, making the product totally biocompatible
• Rehydrates the tissues and favours tissue remodelling
• Indicated for severe xerodermia associated with dermatitis and/or psoriasis
• Sold on medical prescription only, for administration by qualified personnel

Wskazania i zastosowanie profesjonalne

Główne wskazania

• Severe xerodermia associated with dermatitis and/or psoriasis
• Restoration of the normal physiological condition of the dermis
• Rehydration of skin tissue where cell turnover of the stratum corneum is increased

Zastosowanie profesjonalne

Viscoderm 2.0 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.

Obszary zabiegowe

• Intradermal administration, at medium-deep level
• The treating practitioner determines the area treated

Profil pacjenta

Viscoderm 2.0 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 2.0% concentration is indicated to counteract severe xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.

Jak działa Viscoderm 2.0 ​

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty VISCODERM od zweryfikowanych dostawców, z pełną identyfikowalnością partii i wsparciem ekspertów. Obsługujemy kliniki i specjalistów medycyny estetycznej, oferując produkty z oznakowaniem CE, szybką dostawę na terenie całej UE z naszego magazynu w UE oraz konkurencyjne ceny hurtowe. Najważniejsze są dla nas bezpieczeństwo, satysfakcja i efekty Twoich pacjentów - z indywidualnym wsparciem posprzedażowym dla Twojego spokoju.

Najczęściej zadawane pytania